Evidence map›Paper›PMID 33581220›Full record

ReviewRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2021

Mechanisms of radiation-induced endothelium damage: Emerging models and technologies.

Harshani Wijerathne, Jordan C Langston, Qingliang Yang, Shuang Sun, Curtis Miyamoto, Laurie E Kilpatrick, Mohammad F Kiani

Open access · greenAbstract readReview
In one paragraph

Review in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 144 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prophylactic cranial irradiation in the era of immunotherapy in extensive-stage small cell lung cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Harshani WijerathneDepartment of Mechanical Engineering, Temple University, Philadelphia, USA.
Jordan C LangstonDepartment of Bioengineering, Temple University, Philadelphia, USA.
Qingliang YangDepartment of Mechanical Engineering, Temple University, Philadelphia, USA.
Shuang SunCenter for Inflammation, Clinical and Translational Lung Research, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, USA.
Curtis MiyamotoDepartment of Radiation Oncology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA.
Laurie E KilpatrickCenter for Inflammation, Clinical and Translational Lung Research, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, USA; Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, USA; Department of Physiology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA.
Mohammad F KianiDepartment of Mechanical Engineering, Temple University, Philadelphia, USA; Department of Bioengineering, Temple University, Philadelphia, USA; Department of Radiation Oncology, Lewis Katz School of Medicine, Temple University, Philadelphia, USA. Electronic address: mkiani@temple.edu.
Temple University · US

Funding

Leukocyte-Endothelial Cell Interactions in SepsisR01GM114359 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KIANI, MOHAMMAD F, KILPATRICK, LAURIE E · 2015 to 2018
$1.2M
Integrating microfluidic, omic, and in silico models to screen therapeutics for sepsisR01GM134701 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · PI KIANI, MOHAMMAD F, KILPATRICK, LAURIE E · 2019 to 2020
$656k
NIGMS NIH HHS R01 GM114359NIGMS NIH HHS R01 GM134701
6 · The paper itself

Abstract

Radiation-induced endothelial/vascular injury is a major complicating factor in radiotherapy and a leading cause of morbidity and mortality in nuclear or radiological catastrophes. Exposure of tissue to ionizing radiation (IR) leads to the release of oxygen radicals and proteases that result in loss of endothelial barrier function and leukocyte dysfunction leading to tissue injury and organ damage. Microvascular endothelial cells are particularly sensitive to IR and radiation-induced alterations in endothelial cell function are thought to be a critical factor in organ damage through endothelial cell activation, enhanced leukocyte-endothelial cell interactions, increased barrier permeability and initiation of apoptotic pathways. These radiation-induced inflammatory responses are important in early and late radiation pathologies in various organs. A better understanding of mechanisms of radiation-induced endothelium dysfunction is therefore vital, as radiobiological response of endothelium is of major importance for medical management and therapeutic development for radiation injuries. In this review, we summarize the current knowledge of cellular and molecular mechanisms of radiation-induced endothelium damage and their impact on early and late radiation injury. Furthermore, we review established and emerging in vivo and in vitro models that have been developed to study the mechanisms of radiation-induced endothelium damage and to design, develop and rapidly screen therapeutics for treatment of radiation-induced vascular damage. Currently there are no specific therapeutics available to protect against radiation-induced loss of endothelial barrier function, leukocyte dysfunction and resulting organ damage. Developing therapeutics to prevent endothelium dysfunction and normal tissue damage during radiotherapy can serve as the urgently needed medical countermeasures.

Indexed as

Endothelial CellsRadiation InjuriesEndotheliumEndothelium, VascularHumansRadiation, IonizingReactive Oxygen SpeciesReactive Oxygen SpeciesEndothelial cellsInflammatory responseIonizing radiationMicrophysiological systemsPermeabilityRadioprotective agents

Identifiers

PMID33581220
PMCPMC8119342
OpenAlexW3127854198

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.